Beckman Coulter brings the productivity and efficiency benefits of large volume hematology analyzers to small- and medium-sized labs

Rhea-AI Summary

Beckman Coulter announced the launch of the DxH 560 AL, a compact tabletop analyzer designed for small to mid-sized laboratories. This innovative device features Auto-Loading functionality, allowing for continuous sample addition of up to 50, while minimizing manual tasks and resource usage. It requires only 17 μL of blood, making it ideal for difficult-to-draw patients, and delivers results in under 60 seconds. The DxH 560 AL aims to provide large laboratory efficiency at a lower cost, enhancing productivity without exceeding budgetary constraints.

Positive

• DxH 560 AL analyzer reduces time and resources for small to mid-sized labs.
• Requires only 17 μL of sample, the smallest volume available, ideal for difficult-to-draw patients.
• Delivers results in less than 60 seconds, improving workflow efficiency.
• Compact design uses ~30% less counter space than competitors, optimizing laboratory layout.

Negative

• None.

BREA, Calif., Jan. 25, 2021 /PRNewswire/ -- Beckman Coulter, a global leader in clinical diagnostics, announced today the launch of the DxH 560 AL, a tabletop analyzer geared to reduce the time and resource constraints faced by small to mid-sized laboratories. With the analyzer's Auto-Loading functionality, closed tube aspiration and walkaway capabilities, users can continually add up to 50 samples, provide safety against blood-borne pathogens and spend less time on manual instrument tasks. Compactly designed, the DxH 560 AL uses ~30% less counter space than other analyzers in its class.

Smaller labs can now reap the same efficiency and productivity benefits as larger labs without blowing the budget.

The DxH 560 AL delivers results in 60 seconds or less, and is the ideal instrument to use with difficult-to-draw patients (infants, oncology and elderly) as it only needs a 17 μL sample – less than a drop of blood, one of the smallest aspiration volumes on the market. The analyzer also provides industry-leading privacy and security features including customizable user login, paperless data management and fully traceable automated timeouts that guards patient electronic personal health information.

"With proven performance and low-cost to operate, the DxH 560 AL includes the analytical strengths and data management capabilities of high-throughput analyzers in a small footprint," said Peter Soltani, Ph.D., senior vice president and general manager of hematology at Beckman Coulter. "The industry-leading functionality and auto-load capabilities of the DxH 560 AL enables smaller labs to reap the same efficiency and productivity benefits as their larger counterparts without blowing the budget."

The DxH 560 AL is part of Beckman Coulter's DxH 500 series of small footprint tabletop hematology analyzers, including the recently launched DxH 500 and the award winning DxH 520*. The full DxH 500 series of analyzers include dynamic gating for its 5-part differential, eliminating rejected results and lowering manual interventions.

Beckman Coulter's DxH 560 AL builds on the organization's strength in hematology innovation and complements its broad spectrum of hematology analyzers, including the award winning DxH 690T** for mid-volume, DxH 900 for high-volume and DxH connected workcell solutions for ultra-high-volume facilities. For more information on the DxH 560 AL, or the full DxH 500 series, visit https://www.beckmancoulter.com/en/products/hematology.

About Beckman Coulter
Beckman Coulter is committed to advancing healthcare for every person by applying the power of science, technology and the passion and creativity of our teams to enhance the diagnostic laboratory's role in improving healthcare outcomes. Our diagnostic systems are used in complex biomedical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. Beckman Coulter offers a unique combination of people, processes and solutions designed to elevate the performance of clinical laboratories and healthcare networks. We do this by accelerating care with a menu that matters, bringing the benefit of automation to all, delivering greater insights through clinical informatics and unlocking hidden value through performance partnership. An operating company of Danaher Corporation (NYSE: DHR) since 2011, Beckman Coulter is headquartered in Brea, Calif., and has more than 11,000 global associates working diligently to make the world a healthier place.

*Winner of the 2019 SelectScience Scientist's Choice Award for Best News Clinical Instrumentation
**Winner of the 2020 Frost & Sullivan 2020 Global Hematology Testing New Product Innovation Award

© 2021 Beckman Coulter. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

View original content to download multimedia:http://www.prnewswire.com/news-releases/beckman-coulter-brings-the-productivity-and-efficiency-benefits-of-large-volume-hematology-analyzers-to-small--and-medium-sized-labs-301214191.html

SOURCE Beckman Coulter Diagnostics

FAQ

What are the key features of the DxH 560 AL analyzer from Beckman Coulter?

The DxH 560 AL features Auto-Loading functionality, requires only 17 μL of blood, delivers results in under 60 seconds, and is designed for compact spaces.

How does the DxH 560 AL benefit small to mid-sized laboratories?

The DxH 560 AL offers large laboratory efficiency and productivity at a lower cost, allowing smaller labs to operate more effectively without exceeding budgets.

When was the DxH 560 AL launched by Beckman Coulter?

The DxH 560 AL was launched on January 25, 2021.

What company owns Beckman Coulter?

Beckman Coulter is an operating company of Danaher Corporation (NYSE: DHR).